Differential regulation of interleukin-6 expression in human fibroblasts by tumor necrosis factor-alpha and lymphotoxin

FEBS Lett. 1990 Sep 17;270(1-2):152-6. doi: 10.1016/0014-5793(90)81256-n.

Abstract

The treatment of human diploid fibroblasts with tumor necrosis factor (TNF)-alpha and with lymphotoxin (LT) is associated with induction of interleukin-6 (IL-6) transcripts with TNF-alpha being 10-fold more potent than LT. Here we report on the TNF-alpha/LT-induced signaling mechanisms responsible for the regulation of IL-6 gene expression in these cells. Run-on assays demonstrated that both TNF-alpha and LT increase IL-6 mRNA levels by transcriptional activation of this gene. Stability studies of IL-6 transcripts in fibroblasts showed that TNF-alpha delayed IL-6 mRNA decay but not LT. The induction of IL-6 transcripts by TNF-alpha and LT was not inhibited by the isoquinoline sulfonamide derivative H7. Similarly, depletion of protein kinase C (PKC) by 12-O-tetradecanoyl-phorbol 13-acetate (TPA) did not change the ability of TNF-alpha and LT to induce IL-6 transcripts, demonstrating that stimulation by these agents may not be mediated by activation of PKC. Stimulation of IL-6 transcripts in fibroblasts did also not require new protein synthesis as exposure to the protein synthesis inhibitor cycloheximide (CHX) enhanced accumulation of IL-6 mRNA in the presence or absence of TNF-alpha or LT.

Publication types

  • Research Support, Non-U.S. Gov't
  • Retracted Publication

MeSH terms

  • Cells, Cultured
  • Fibroblasts / metabolism*
  • Gene Expression Regulation
  • Humans
  • Interleukin-6 / biosynthesis*
  • Interleukin-6 / genetics
  • Kinetics
  • Lymphotoxin-alpha / physiology*
  • Protein Biosynthesis
  • Protein Kinase C / physiology
  • RNA, Messenger / metabolism
  • Time Factors
  • Transcription, Genetic
  • Tumor Necrosis Factor-alpha / physiology*

Substances

  • Interleukin-6
  • Lymphotoxin-alpha
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Protein Kinase C